AZN - AstraZeneca PLC ADR
AstraZeneca PLC ADR Logo

AZN - AstraZeneca PLC ADR

https://www.astrazeneca.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.

52W High
$82.41
52W Low
$60.83
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.17
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
30.71
Forward P/E (<15 better)
15.87
EV/EBITDA (<8 favorable)
16.49
EV/Revenue (<3 favorable)
4.92
P/S (TTM) (<3 favorable)
4.50
P/B (<3 favorable)
5.66
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
16.74%
Shares Outstanding
3,100,500,000
Float
1,542,932,000
Dividend Yield (2–6% sweet spot)
0.02%
Ex‑Dividend Date
2025-08-08
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
56,500,998,000
Gross Profit (TTM)
46,479,999,000
EPS (TTM)
2.66
Profit Margin (>10% good)
0.15%
Operating Margin (TTM) (higher better)
0.24%
ROE (TTM) (>15% strong)
0.20%
EPS YoY (Quarterly) (>10% good)
0.28
Revenue YoY (Quarterly) (>8% good)
0.12
Momentum
Bearish momentum
Value
1.5725
Previous
1.8542
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025